The interaction of HA and CD44 promotes EGFR-mediated pathways, consequently leading to tumor cell growth, tumor cell migration, and chemotherapy resistance in breast, prostate, and gastrointestinal cancers (100). This evidence concerns the gene CD44 and neoplasm.